CAS 1314801-63-2

AT 1001

CAS : 1314801-63-2

AT 1001 is a drug that has been demonstrated to be effective in the treatment of bowel disease. It is specifically designed to bind to acetylcholine receptors on the cell membrane, thereby blocking the action of acetylcholine and reducing inflammation. AT 1001 has been shown to be effective in animal models of autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease. This drug has also been shown to have some effect on otoacoustic emissions and locomotor activity in animals. The binding site for this drug is known, but its exact mechanism of action is not yet clear.

Formule : C₁₄H₁₉BrN₂

Degré de pureté : Min. 95%

Masse moléculaire : 295.22 g/mol

Ref: 3D-PCC80163

AT-1001

CAS : 1314801-63-2

AT-1001 is an α3β4 nAChR partial agonist reducing nicotine relapse and withdrawal with negligible impact on food response and dopamine release.

Formule : C₁₅H₂₁BrN₂

Couleur et forme : Solid

Masse moléculaire : 309.24

Ref: TM-T70987